Press Releases April 23, 2026 07:00 AM

Malibu Boats, Inc. Announces Earnings Release Date and Conference Call Information for Third Quarter Fiscal 2026 Financial Results

Malibu Boats Announces Q3 Fiscal 2026 Earnings Release and Conference Call Details

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
MBUU

Malibu Boats, Inc. will release its third quarter fiscal 2026 financial results on May 7, 2026, after market close, followed by a management conference call. The call will be hosted by CEO Steve Menneto and CFO David Black, providing insights into the company's performance. Malibu Boats is a leading manufacturer of recreational powerboats, including sport, sterndrive, outboard, fishing, and adventure dayboats, holding strong positions in multiple boat market segments.

Malibu Boats, Inc. Announces Earnings Release Date and Conference Call Information for Third Quarter Fiscal 2026 Financial Results
MBUU
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Malibu Boats to announce Q3 fiscal 2026 financial results on May 7, 2026.
  • Conference call hosted by CEO and CFO to discuss earnings and business updates.
  • Company is a market leader in various segments of recreational powerboats, including sport, sterndrive, saltwater fishing, and premium adventure dayboats.

LOUDON, Tenn., April 23, 2026 (GLOBE NEWSWIRE) -- Malibu Boats, Inc. (Nasdaq: MBUU) (“Malibu”, “MBI” or the “Company”), today announced that it will release its third quarter fiscal 2026 financial results on Thursday, May 7, 2026, after the market closes. Following the release, the company’s management will host a conference call to discuss the results at 5:00 p.m. Eastern Time on the same day.

The call will be hosted by Malibu’s President and Chief Executive Officer, Steve Menneto, and Chief Financial Officer, David Black.

Investors and analysts are invited to listen to the conference call by dialing (800) 715-9871 or +1 (646) 307-1963. Alternatively, interested parties can listen to a live webcast of the conference call by logging on to the Investor Relations section on the Company’s website at https://malibuboatsinc.com/investor-information/events-presentations. A replay of the webcast will also be archived on the Company’s website for twelve months.

About Malibu Boats, Inc.

Based in Loudon, Tennessee, Malibu Boats, Inc. (MBUU) is a leading designer, manufacturer and marketer of a diverse range of recreational powerboats, including performance sport, sterndrive and outboard boats. Malibu Boats, Inc. is among the market leaders in the performance sport boat category through its Malibu and Axis boat brands, among the market leaders in the 20’ - 40’ segment of the sterndrive boat category through its Cobalt brand, among the market leaders in the saltwater fishing boat market with its Pursuit and Cobia offshore boats and Pathfinder, Maverick, and Hewes flats and bay boat brands, and among the market leaders in the premium adventure dayboat market with its Saxdor brand. A pre-eminent innovator in the powerboat industry, Malibu Boats, Inc. designs products that appeal to an expanding range of recreational boaters, fisherman and water sports enthusiasts whose passion for boating is a key component of their active lifestyles. For more information, visit www.malibuboats.com, www.axiswake.com, cobaltboats.com, www.pursuitboats.com, www.maverickboatgroup.com, or www.saxdoryachts.com.

Contacts:

Investor Relations:
[email protected]


Risks

  • Earnings results may not meet market expectations leading to stock price volatility.
  • Market demand for recreational boats can be affected by economic conditions impacting consumer spending.
  • Potential supply chain or production issues could affect delivery schedules and financial performance.

More from Press Releases

Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026 Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1 Jun 12, 2026